Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes

Detalles Bibliográficos
Autores principales: Zhao, Houyu, Zhuo, Lin, Sun, Yexiang, Shen, Peng, Lin, Hongbo, Zhan, Siyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345969/
https://www.ncbi.nlm.nih.gov/pubmed/37169365
http://dx.doi.org/10.1111/1753-0407.13408
_version_ 1785073210032652288
author Zhao, Houyu
Zhuo, Lin
Sun, Yexiang
Shen, Peng
Lin, Hongbo
Zhan, Siyan
author_facet Zhao, Houyu
Zhuo, Lin
Sun, Yexiang
Shen, Peng
Lin, Hongbo
Zhan, Siyan
author_sort Zhao, Houyu
collection PubMed
description
format Online
Article
Text
id pubmed-10345969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-103459692023-07-15 Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes Zhao, Houyu Zhuo, Lin Sun, Yexiang Shen, Peng Lin, Hongbo Zhan, Siyan J Diabetes Letters to the Editor Wiley Publishing Asia Pty Ltd 2023-05-11 /pmc/articles/PMC10345969/ /pubmed/37169365 http://dx.doi.org/10.1111/1753-0407.13408 Text en © 2023 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Zhao, Houyu
Zhuo, Lin
Sun, Yexiang
Shen, Peng
Lin, Hongbo
Zhan, Siyan
Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title_full Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title_fullStr Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title_full_unstemmed Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title_short Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
title_sort response to: critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345969/
https://www.ncbi.nlm.nih.gov/pubmed/37169365
http://dx.doi.org/10.1111/1753-0407.13408
work_keys_str_mv AT zhaohouyu responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes
AT zhuolin responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes
AT sunyexiang responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes
AT shenpeng responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes
AT linhongbo responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes
AT zhansiyan responsetocriticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes

Ejemplares similares